Medicare Enrolled

Dr. Guadalupe Pedrano, M.D.

Dermatology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2209 N SAN FERNANDO RD, Los Angeles, CA 90065
3232260511
In practice since 2008 (17 years)
NPI: 1174786073 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pedrano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pedrano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pedrano

Dr. Guadalupe Pedrano is a dermatology specialist in Los Angeles, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Pedrano performed 215 Medicare services across 140 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pedrano received a total of $681 from 7 pharmaceutical and/or device companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pedrano is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ 215 Medicare services $681 industry payments

Medicare Practice Summary

Medicare Utilization ↗
215
Medicare services
Bottom 29% in CA for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
140
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~13 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 100 $71 $1,087
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
 42 $48 $85
Annual depression screening 20 $21 $45
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
 19 $140 $200
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
 18 $32 $33
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
 16 $72 $75
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$681
Total received (2018-2024)
Avg $97/year across 7 years
Top 31% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
7
Companies
24
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$681 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$162
2023
$42
2022
$117
2021
$63
2020
$113
2019
$131
2018
$52

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ANI Pharmaceuticals, Inc.
$110
Bayer Healthcare Pharmaceuticals Inc.
$52
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$179
Merck Sharp & Dohme LLC
$142
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$131
ANI Pharmaceuticals, Inc.
$110
Bayer Healthcare Pharmaceuticals Inc.
$52
Amarin Pharma Inc.
$49
PFIZER INC.
$17
Top 3 companies account for 66.5% of all-time payments
Associated products mentioned in payments ›
BELSOMRA · JANUVIA · Kerendia · PAXLOVID · PURIFIED CORTROPHIN GEL · STEGLATRO · TRULANCE · VERQUVO · Vascepa · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in Los Angeles?
Compare dermatologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
549
Per 100K population
5.6
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
2.6 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pedrano is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pedrano experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Pedrano performed 100 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pedrano receive payments from pharmaceutical companies?
Yes. Dr. Pedrano received a total of $681 from 7 companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pedrano's costs compare to other dermatologists in Los Angeles?
Dr. Pedrano's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pedrano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Dermatology
Common procedures, typical costs, and what industry payments mean in dermatology.
Same specialty & city
Dermatologists in Los Angeles
Browse dermatologists in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →